Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKTS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
AKTS
Aktis Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKTS
Aktis Oncology, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
AKTS
with
LLY
Uncorrelated: r 0.17 · 188D.
No shared co-movers.
AKTS, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
AKTS
Aktis Oncology, Inc.
Change
14.81
▼
−2.56%
· post 14.81
· delayed
Mkt cap
$840.6M
Revenue
$3M
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,362.90
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 5 '26
delayed
AKTS
Aktis Oncology, Inc.
vs
LLY
ELI Lilly & Co
14.81
▼
−2.56%
post 14.81
delayed
Price
1,371.32
▼
−3.29%
post 1,362.90
delayed
$840.6M
Mkt cap
$1.3T
Q2 FY26
$3M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
AKTS
14.81
▼
−2.56%
vs
LLY
1,371.32
▼
−3.29%
After hours
Nov 5 '26
delayed